Naser Pour-Ansari

Oxford, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 38 publications

NGS-based targeted sequencing guides risk-adapted and molecularly targeted therapy decisions in multiple myeloma.

NGS-based targeted sequencing guides risk-adapted and molecularly targeted therapy decisions in multiple myeloma.

Journal: British journal of haematology

Published: April 17, 2025

Quantitative liver function imaging and whole genome sequencing - Effective modalities for a new era in personalised decision-making for operable colorectal liver metastases?

Quantitative liver function imaging and whole genome sequencing - Effective modalities for a new era in personalised decision-making for operable colorectal liver metastases?

Journal: HPB : the official journal of the International Hepato Pancreato Biliary Association

Published: October 17, 2024

Detecting and quantifying clonal selection in somatic stem cells.

Detecting and quantifying clonal selection in somatic stem cells.

Journal: Nature genetics

Published: October 10, 2023

Cancer origin tracing and timing in two high-risk prostate cancers using multisample whole genome analysis: prospects for personalized medicine.

Cancer origin tracing and timing in two high-risk prostate cancers using multisample whole genome analysis: prospects for personalized medicine.

Journal: Genome medicine

Published: April 13, 2023

The genomic landscape and clonal evolutionary trajectory of classical hairy cell leukemia.

The genomic landscape and clonal evolutionary trajectory of classical hairy cell leukemia.

Journal: Leukemia

Published: November 02, 2022

In silico engineering a CD80 variant with increased affinity to CTLA-4 and decreased affinity to CD28 for optimized cancer immunotherapy.

In silico engineering a CD80 variant with increased affinity to CTLA-4 and decreased affinity to CD28 for optimized cancer immunotherapy.

Journal: Journal of immunological methods

Published: June 25, 2022

Whole-genome analysis identifies novel drivers and high-risk double-hit events in relapsed/refractory myeloma.

Whole-genome analysis identifies novel drivers and high-risk double-hit events in relapsed/refractory myeloma.

Journal: Blood

Published: May 09, 2022

Landscape of Genetic Alterations Underlying Hallmark Signature Changes in Cancer Reveals TP53 Aneuploidy-driven Metabolic Reprogramming.

Landscape of Genetic Alterations Underlying Hallmark Signature Changes in Cancer Reveals TP53 Aneuploidy-driven Metabolic Reprogramming.

Journal: Cancer research communications

Published: March 12, 2022

Loss of COP9 signalosome genes at 2q37 is associated with IMiD resistance in multiple myeloma.

Loss of COP9 signalosome genes at 2q37 is associated with IMiD resistance in multiple myeloma.

Journal: Blood

Published: February 14, 2022

Clonal diversification and histogenesis of malignant germ cell tumours.

Clonal diversification and histogenesis of malignant germ cell tumours.

Journal: Nature communications

Published: January 26, 2022

Myeloma Genome Project Panel is a Comprehensive Targeted Genomics Panel for Molecular Profiling of Patients with Multiple Myeloma.

Myeloma Genome Project Panel is a Comprehensive Targeted Genomics Panel for Molecular Profiling of Patients with Multiple Myeloma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: October 19, 2021

Re-evaluating experimental validation in the Big Data Era: a conceptual argument.

Re-evaluating experimental validation in the Big Data Era: a conceptual argument.

Journal: Genome biology

Published: February 25, 2021

Showing 1-12 of 38

Last Updated: 09/26/2026